Policy update: HHS enforcement discretion now covers six compounded peptides for individual patients. Empower is bringing all six to our formulary.

Compounded peptide updates from Empower Pharmacy

Peptide Resources for Providers

Your patients are already asking about peptides. Start with prescriber guides and policy news from the PCAB-accredited pharmacy behind the prescription.

PCAB accredited LegitScript certified

PCAB-accredited 503A pharmacy.
LegitScript certified.

Empower compounded peptides: KPV, GHK-Cu and BPC-157 capsules, Semax nasal spray, BPC-157 troche, and Epitalon, TB-500, BPC-157 and MOTS-c injection vials

Start Here

Peptide Policy, Coverage, & Provider Resources

The regulatory landscape is evolving. These resources keep your practice ahead of it.

Policy guide

Prescriber's Guide to the HHS Peptide Policy

What the policy covers, what a pharmacy has to do to qualify, and what to ask before you prescribe.

Read the prescriber's guide

Knowledge Center

Peptides Knowledge Center

Provider-focused articles and resources on peptide compounding, in one place.

Browse peptide resources

Stay informed

Get Peptide Updates

Policy updates and prescriber guides for your practice, plus a notice when peptide availability changes.

  • New guides and policy changes, as they publish
  • A notice when peptide availability changes
  • Opt out at any time

Compounded medications require a prescription and are not FDA-approved. Availability depends on federal and state requirements. This form does not place an order.

TELL US WHO YOU ARE:

Learn more about how you can access compounded medications with a prescription.

We may reach out with updates on products, promotions, and services.
You can opt out at any time.

Sign up for updates on availability, regulatory changes, and educational resources from Empower.

We may reach out with updates on products, promotions, and services.
You can opt out at any time.

Sign up for updates on availability, regulatory changes, and educational resources from Empower.

We may reach out with updates on products, promotions, and services.
You can opt out at any time.

Peptide line-up

HHS-covered routes and Empower formulations

The six peptides now covered under the HHS policy: the routes the policy covers for each, and the formulations we compound.

Six HHS-covered peptides

Jar of BPC-157 capsules

HHS covered routesSubcutaneous, intramuscular, oral, topical

Empower formulationsCapsule 500 mcg and 1,000 mcg · Troche 1,000 mcg · Injection 3 mg/mL

TB-500 3 mg/mL injection vial

HHS covered routesSubcutaneous, intramuscular

Empower formulationsInjection 3 mg/mL

MOTS-c 2 mg/mL injection vial

HHS covered routesSubcutaneous, intramuscular

Empower formulationsInjection 2 mg/mL

Epitalon 10 mg/mL injection vial

HHS covered routesSubcutaneous, intramuscular, in intermittent courses

Empower formulationsInjection 10 mg/mL

Semax 7.5 mg/mL nasal spray bottle

HHS covered routesIntranasal

Empower formulationsNasal spray 7.5 mg/mL

Jar of KPV capsules

HHS covered routesTopical, oral

Empower formulationsCapsule 500 mcg

Also on our formulary: GHK-Cu (capsule, scalp solution and facial serum), Sermorelin injection, Gonadorelin injection.

Peptide stacks

Prescribing more than one peptide?

Each peptide is its own single-ingredient prescription, in line with the HHS policy. Write a prescription for each, and we'll dispense each as its own labeled product, shipped together.

A pharmacist placing individually packaged products into one shipping box

Frequently Requested Peptide Stacks

Also available: the metabolic stack (MOTS-c with the tirzepatide / niacinamide injection) and a BPC-157 and KPV capsule bundle.

Pricing and state availability vary by product.

Request Pricing & Information

Compounded medications require a prescription and are not FDA-approved. The HHS policy is interim enforcement discretion, not approval, and may change. Availability depends on federal and state requirements. Routes shown are those covered by the policy for each substance; Empower offers the formulations listed.

Why partner with Empower

Why partner with Empower for peptide prescriptions

When patients are counting on you, count on us.

Every peptide we compound moves through the same quality system behind everything we make. Three more reasons providers partner with us.

Empower pharmacy team members working at fulfillment stations

01

Scale

Capacity for a national platform, attention for a single practice

Licensed across the country, with the capacity to serve a single practice or a national platform.

02

Transparency

You see what the price covers

Qualified sourcing, release testing, pharmacist oversight. The price reflects the process.

03

Support

Easy to start, supported from day one

Prescribe the way you already do, with an account team and pharmacists to support your patients' needs.

PCAB accredited LegitScript certified

FAQ

Frequently asked questions about Empower peptides

Answers about how Empower sources, tests and supports peptide prescriptions.

Policy questions? The prescriber's guide to the HHS peptide policy answers them, and the covered peptides matrix shows form and route for each peptide.

What Is the HHS Peptide Enforcement Discretion Policy?

HHS’s peptide enforcement discretion policy is a statement that it does not intend to take enforcement action against certain peptide compounding when specific conditions are met. It is a draft interim policy that is not binding on HHS or the public, and it does not change Section 503A. The policy stays in place while FDA builds the 503A bulk drug substances list through rulemaking.¹ It applies to state-licensed pharmacies, Federal facilities, and licensed physicians. A “licensed physician” here means one who compounds, not prescribers in general.

For prescribers, this changes the federal enforcement picture for the pharmacies you can work with, but it does not impact any state-specific laws or regulations that may exist in your state.

Which Peptides Does the Policy Cover?

Six: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. Each is limited to the specific form and routes listed. A peptide not on the list, or in a different form or route, is outside the policy.

Source: Appendix B of the HHS policy. Appendix B defines each peptide by exact sequence and formula. For instance, it describes TB-500 as a fragment of its parent protein, thymosin beta-4. The full text is in the Federal Register notice.

Do Prescribers Need a Patient-Specific Prescription?

Yes. The policy names section 503A’s patient-specific prescription requirement as one of its conditions

The clinical decision for each patient is still yours. Consider documenting:

  • Your clinical rationale for each individual patient
  • Patient consent, including that the product is compounded and not FDA-approved
  • The specific peptide, form, and route, checked against Appendix B
Is a Compounded Peptide FDA-Approved?

No. Compounded drugs are not FDA-approved, which means FDA does not review their safety, effectiveness, or quality before they are marketed. None of these six peptides is an FDA-approved drug.

HHS states that its policy is meant to expand patient access while FDA reviews these substances. Enforcement discretion describes how HHS intends to use its enforcement resources. It is not an approval of any peptide or compounded product.

Where did the active ingredient come from?

An FDA-registered original manufacturer, with a Certificate of Analysis reviewed for each lot.

Can I see testing, not just a purity number?

Each batch is released with a Certificate of Conformance. Prescribers can request it.

What is a COC, and what is a COA?

A Certificate of Conformance (COC) is Empower's batch-release document for a finished peptide; prescribers can request it. A Certificate of Analysis (COA) comes from the active ingredient manufacturer for each lot and, as reported, must show the manufacturer's location under the HHS policy. Confirm details in the policy text.

Stay informed on peptide policy and availability

Sign up for updates on availability, regulatory changes, and educational resources from Empower.

Existing customer?LifeFile Login

Compounded medications are prescribed by licensed providers and prepared for individual patients. They are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they are dispensed. This page makes no claims about the safety or efficacy of any product. Availability depends on federal and state requirements and may change. Serious adverse events and product-quality concerns are reported to FDA MedWatch and the state board, as the policy requires.